|
|
||||||||
Article |
We have investigated the influence of endogenous nitric oxide (NO) on the vascular resistance of isolated rat lungs by inhibiting its synthesis with the false substrate N-monomethyl-L-arginine (L-NMMA). When perfused with blood at constant flow the addition of L-NMMA (10(-3) M) did not affect pulmonary arterial pressure in hyperoxia but did increase the response to hypoxia (PO2 25-35 mmHg) by 2.5 +/- 0.2 fold (mean +/- S.E.M.). The effect of L-NMMA was reversed by 3 x 10(-3) M-L-arginine, the true substrate for NO synthesis. Thus NO is an important pulmonary vasodilator but hypoxic vasoconstriction does not result from a reduction of its background release.
This article has been cited by other articles:
![]() |
T. C. Resta, B. R. Walker, M. R. Eichinger, and M. P. Doyle Rate of NO scavenging alters effects of recombinant hemoglobin solutions on pulmonary vasoreactivity J Appl Physiol, October 1, 2002; 93(4): 1327 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hampl and J. Herget Role of Nitric Oxide in the Pathogenesis of Chronic Pulmonary Hypertension Physiol Rev, October 1, 2000; 80(4): 1337 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Hakim, L. Ferrario, J. C. Freedman, R. E. Carlin, and E. M. Camporesi Segmental pulmonary vascular responses to ATP in rat lungs: role of nitric oxide J Appl Physiol, March 1, 1997; 82(3): 852 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mehta, D. J. Stewart, D. Langleben, and R. D. Levy Short-term Pulmonary Vasodilation With L-Arginine in Pulmonary Hypertension Circulation, September 15, 1995; 92(6): 1539 - 1545. [Abstract] [Full Text] |
||||
![]() |
A. T. Dinh-Xuan, T. W. Higenbottam, and J. Wallwork Relationship between Chronic Hypoxia and In Vitro Pulmonary Relaxation Mediated by Endothelium-Derived Relaxing Factors in Human Chronic Obstructive Lung Disease Angiology, April 1, 1992; 43(4): 350 - 356. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |